HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Milan Hora Selected Research

Milan Hora Research Topics

Disease

41Neoplasms (Cancer)
02/2022 - 06/2006
30Renal Cell Carcinoma (Grawitz Tumor)
01/2022 - 02/2013
10Kidney Neoplasms (Kidney Cancer)
01/2022 - 12/2013
6Neoplasm Metastasis (Metastasis)
10/2021 - 09/2013
4Carcinoma (Carcinomatosis)
10/2021 - 06/2013
4Prostatic Neoplasms (Prostate Cancer)
04/2021 - 09/2015
2Adenocarcinoma
09/2020 - 01/2005
2Leiomyomatosis
04/2019 - 01/2019
2Thrombosis (Thrombus)
01/2016 - 05/2015
2Hemorrhage
04/2014 - 05/2009
1Penile Neoplasms (Penile Cancer)
01/2021
1Metaplasia
09/2020
1Villous Adenoma
09/2020
1Insulinoma
07/2019
1Transitional Cell Carcinoma
01/2018
1Necrosis
02/2017
1Intraoperative Complications
01/2016
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2015
1Papillary Carcinoma
07/2014
1Seminoma
04/2014
1Nodular Goiter
04/2014
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2013
1Hyperaldosteronism (Conn Syndrome)
01/2013
1Hypertension (High Blood Pressure)
01/2013
1Sex Cord-Gonadal Stromal Tumors (Sex Cord-Stromal Tumor)
07/2011
1Granulosa Cell Tumor
07/2011

Drug/Important Bio-Agent (IBA)

7NivolumabIBA
10/2021 - 01/2016
7Sunitinib (Sutent)FDA Link
10/2021 - 10/2015
7AntigensIBA
12/2018 - 02/2008
7VimentinIBA
08/2018 - 04/2010
6Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2015
6ParvalbuminsIBA
12/2016 - 02/2008
5cabozantinibIBA
10/2021 - 01/2016
5IpilimumabIBA
10/2021 - 03/2018
5Biological ProductsIBA
02/2017 - 07/2009
4Immune Checkpoint InhibitorsIBA
01/2022 - 08/2019
4pembrolizumabIBA
01/2022 - 08/2019
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 10/2015
4Mucin-1 (CA 15-3 Antigen)IBA
12/2016 - 02/2008
3trans-sodium crocetinate (crocetin)IBA
02/2022 - 12/2021
3Capsules (Microcapsules)IBA
01/2022 - 04/2014
3Axitinib (AG 013736)IBA
10/2021 - 08/2019
3Prostate-Specific Antigen (Semenogelase)IBA
04/2021 - 09/2015
3Chromogranin AIBA
07/2019 - 04/2014
3Fumarate Hydratase (Fumarase)IBA
04/2019 - 08/2017
3Keratin-7 (Cytokeratin 7)IBA
03/2019 - 07/2013
3Messenger RNA (mRNA)IBA
08/2017 - 02/2013
3Formaldehyde (Formol)FDA Link
08/2017 - 06/2006
3ParaffinIBA
08/2017 - 06/2006
2Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2012
2pazopanibFDA Link
01/2021 - 01/2021
2LigandsIBA
01/2021 - 08/2017
2SynaptophysinIBA
07/2019 - 08/2015
2MucinsIBA
02/2019 - 07/2016
2Carbonic Anhydrase IXIBA
10/2015 - 04/2014
2Androgen Receptors (Androgen Receptor)IBA
07/2014 - 04/2014
2Racemases and Epimerases (Epimerases and Racemases)IBA
07/2013 - 04/2010
1Pharmaceutical PreparationsIBA
01/2022
1Death Domain ReceptorsIBA
01/2022
1lenvatinibIBA
10/2021
1Complement System Proteins (Complement)IBA
10/2021
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2021
1Metformin (Glucophage)FDA LinkGeneric
01/2021
1Colloids (Colloid)IBA
09/2020
1IodineIBA
01/2018
1DNA (Deoxyribonucleic Acid)IBA
01/2017
1TOR Serine-Threonine KinasesIBA
01/2017
1EverolimusFDA Link
01/2017
1Cathepsin KIBA
12/2016
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
11/2016
1ORALIT (ORS)IBA
01/2016
1Therapeutic UsesIBA
10/2015
1Hypoxia-Inducible Factor 1IBA
10/2015
1Phosphopyruvate Hydratase (Enolase)IBA
08/2015
1mesoglycanIBA
05/2015
1N-acetyltalosaminuronic acid (NAT)IBA
12/2014
1CAM 5.2 antigenIBA
04/2014
1Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
04/2014
1ThyroglobulinFDA Link
04/2014
1Keratin-20 (Cytokeratin 20)IBA
04/2014
1Human beta Subunit Chorionic GonadotropinIBA
04/2014
1Coenzyme A (CoA)IBA
07/2013
1CreatineIBA
06/2013
1Contrast MediaIBA
06/2013
1Choline (Choline Chloride)IBA
06/2013
1Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
02/2013
1Mitogen-Activated Protein KinasesIBA
02/2013
1ReninIBA
01/2013
1Forkhead Box Protein L2IBA
07/2011
1Laminin (Merosin)IBA
04/2010

Therapy/Procedure

13Therapeutics
02/2022 - 02/2013
9Nephrectomy
10/2021 - 08/2007
4Prostatectomy (Retropubic Prostatectomy)
01/2018 - 01/2005
3Lymph Node Excision (Lymph Node Dissection)
01/2021 - 01/2005
1Operative Surgical Procedures
05/2016
1Nephroureterectomy
05/2016
1Conversion to Open Surgery
01/2016
1Transurethral Resection of Prostate (TURP)
04/2015
1Drug Therapy (Chemotherapy)
03/2015
1Adrenalectomy
09/2013